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The complement system (C-system) l is one of the principal mediators of the biological effects 
after the antigen-antibody  reaction. Up to now 18 distinct complement components have been 
defined including 11 acting in the classical  pathway of complement activation. 
Hereditary deficiencies of components of the C-system were first discovered in experimental 
animals (1-3).  In  1960 a  clinically healthy man was reported with  low  levels of hemolytic 
complement caused by a deficiency of the second component of complement (4) which could 
be shown to be a genetically inherited disorder (5). Subsequently, hereditary deficiencies have 
been described  for  almost  all classical  complement components. The  hereditary deficiency 
reported most frequently is that of C2. Homozygous or heterozygous deficiency of C2 has been 
found in both healthy individuals and in association with systemic or discoid lupus erythema- 
tosus,  dermatomyositis, various forms  of vasculitis, anaphylactoid purpura, and  rheumatic 
diseases  (6-19). Fu et al. (16, 20, 21) and Day et al.  (22) were the first to study HLA markers 
in families with inherited deficiencies of the C2 complement component. They found that C2 
deficiency gene(s)  (C2 °)  segregated  in coupling with  the  haplotype  HLA-A10,BI8. These 
observations could be confirmed by others (23-26). Furthermore HLA-D typing in such families 
revealed a close association between the C2 °  gene(s) and the HLA-DW2 allele. This was first 
shown by Fu et al.  (16, 21) and subsequently confirmed by several  authors (23, 27, 28). The 
complete deficiency of the C4 complement component was first described by Hauptmann et al. 
(29) in a patient with systemic lupus'erythematosus. In a family segregation study of this case, 
Rittner et al. (30) demonstrated a close linkage between the C4 ° gene(s) and the HLA-complex. 
The C4 °  gene segregated with the haplotype HLA-A2,B40,CW3; BfS, carrying hitherto an 
undefined HLA-D allele (RE)  (31). The propositus was homozygous for the entire haplotype. 
In 1977 Ochs et al. (32) described in a second family the close linkage between the C4 ° gene(s) 
and HLA. In this case the C4 °  genes were inherited with the haplotypes HLA-A2,BI2,DW2; 
BtS (maternal) and HLA-A2,BI5,DW8; BfS (paternal). 
Studies  in  other  species  showed  a  striking homology  in  the  association  between  some 
complement components and  the  MHC.  For  the  mouse system  it  could be  demonstrated 
(33-35)  that  the  serum protein coded  for  by the  S-region in the  H-2 complex  (36)  is  the 
homologue  of  human  C4.  Furthermore  Ferreira  and  Nussenzweig  (37) showed  that  the 
functional activity of C3  is  linked  to  H-2  during ontogeny.  In  1976 Shevach  et  al.  (38) 
demonstrated that  a  C4  deficiency gene  is  closely  linked to  the  major  histocompatibility 
complex (MHC)  of the guinea pig. In analogy to man a  close  linkage of the  Bf locus (C3- 
proactivator) and the MHCI of the rhesus monkey has been demonstrated (39). 
The close functional relationship between C2 and C4 in the classical pathway of complement 
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activation and the gametic association between C2 deficiency and HLA-DW2 mentioned above 
prompted us to investigate C2 and C4 serum levels in unrelated healthy HLA-DW2 positive 
and negative blood donors. 
Materials  and  Methods 
Serum Samples.  Serum samples were obtained by prior centrifugation of whole blood allowed 
to clot at room temperature for about 30 min and then at 4°C for 60 min. The sera were stored 
at -80°C in small volumes and were thawed only once for determinations of C2 and C4. 
C2 and 6"4 Measurements.  Serum concentrations of 124 were measured by radial immunodif- 
fusion with commercial plates (Behring-Werke AG, Marburg/Lahn, West Germany). C2 was 
measured by hemolytic titration. Sheep erythrocytes were optimally sensitized with anti-sheep 
erythrocyte antibodies (40).  EAC4 and EAC 14 intermediates were prepared according to the 
method  of Borsos and  Rapp  and  Borsos et  al.,  (41,  42)  and  Ruddy et  al.  (43).  Before the 
incubation  with  EACI4 cells whole human  sera were  treated with  iodine to  stabilize and 
increase C2 hemolytic activity by using the method of Poiley (44).  EAC142 cells were lysed by 
the addition of guinea pig.serum with 0.04 M  EDTA (ethylene diaminotetraacetic acid) added. 
All titrations were done in sucrose-veronal-buffered saline with 0.03%  gelatine added at  an 
incubation temperature of 37°C. To reduce methodological variabilities all sera were titered on 
the same day by using the same reagents, cell intermediates, buffers, and incubation conditions. 
Lysis in the assays was determined spectrophotometricaily from the supernatant hemoglobin at 
412  nm.  The  extinction  values  were  punched  on  paper  tape  and  the  CH50  values  were 
calculated by  a  digital computer with  a  program  that  fitted linear regression lines  to  the 
experimental points. 
HLA  Typing.  A set of more than 90 highly selected antisera was used for HLA-A and -B 
typing, according to the method described by Terasaki and McClelland (45). Typing for HLA- 
D was performed in a microculture system with  1 ×  105 responding and  1 ×  105 stimulating 
cells (R-irradiated with 2,500 rads) using established workshop homozygous typing cells. Details 
of this  method  are  given  in  previous  publications  (46,  47).  The  mixed  leukocyte culture 
stimulation results obtained in mean counts per minute from triplicates were recalculated in so- 
called stabilized relative responses, according to the method of Thomsen et al. (48) with some 
modifications (49). 
Statistical  Evaluation.  To  characterize the  bimodality of the  distributions of C2  and  C4 
values obtained logarithmic Gaussian distributions were optimally fitted to the experimental 
curves using a FORTRAN computer program (50). 
Results 
C2 Determinations.  Hemolytic C2  complement  levels were  measured  in  62  HLA- 
DW2  positive and  64  HLA-DW2  negative unrelated  healthy  individuals. For both 
the HLA-DW2 positive and the HLA-DW2 negative population bimodal distributions 
of C2 serum activities were obtained (Fig.  1). The mean values and ranges of the two 
groups  in  the  HLA-DW2  positive and  HLA-DW2  negative  individuals were  very 
similar (Table I). In addition the modal values were similar in both cases (Fig.  1)  (5 
×  10  a and  12  ×  10  a U  C2/ml) with a ratio of approximately 1:2. Although the shape 
of  the  curves  was  similar  in  the  HLA-DW2  positive  and  HLA-DW2  negative 
population  the  difference of distribution of the  low  and  high  C2  titer  groups  was 
statistically significant (X  2 =  8.13, P  =  0.004  for the X  2 -  test; the frequency values 
for the entries of the 2  ×  2 table were taken from the theoretical distributions). 63% 
of  the  HLA-DW2  positive  population  but  only  37%  of  the  HLA-DW2  negative 
population had C2 levels in the low group. On the other hand only 37% of the HLA- 
DW2  positive population but  63%  of the HLA-DW2  negative population had high 
C2 levels. A  second bleeding of some of the individuals was taken 6 mo later to see if 
the results of the first bleeding were stable with  time  (Fig. 3).  The C2  levels of five 
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the second bleeding thus making it unlikely that the bimodal titer distribution curves 
were due to transient functional variations (r  -- 0.995, P <  0.001). 
C4 Determinations.  C4 protein was measured by immunodiffusion in 64 HLA-DW2 
positive and  72  HLA-DW2 negative unrelated  healthy individuals.  C4 serum levels 
revealed in both populations a  bimodal distribution  although the bimodality in the 
HLA-DW2 negative group was not as distinct  as the one of the HLA-DW2 positive 
group (Fig. 2).  39% of the HLA-DW2 positive population but only 15% of the HLA- 
DW2 negative population had low C4 protein levels whereas 61% of the HLA-DW2 
positive individuals  and  85%  of the  HLA-DW2  negative  individuals  had  high  C4 
protein levels. The mean values and ranges of the C4 concentrations were similar in 
the HLA-DW2 positive and negative individuals  (Table I). The modal values were 
around 30 and 42 mg/100 ml which corresponds to a  ratio of 1:1.4. 
Taking the same criteria as for the C2 investigation the difference in the contribu- 
tion to the high and low C4 level groups between the HLA-DW2 positive and HLA- 
DW2 negative individuals was statistically significant  (X  2 =  9.84, P  =  0.0017).  The CH.  NERL,  H.  GROSSE-WILDE, AND G.  VALET 
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HLA-DW2,Positive  I tI,A-I)W2 Negative 
n  CH50/ml serum  %  n  C1150/ml serum  % 
Total C2  62  7,280  ±  5,138  100  64  q,340  +  4,772  100 
Low C2 individuals  39  3,530  ±  1,801  63  24  4,130  "+  1,620  37 
ltigh C2 individuals  23  11,530 +  4,277  37  40  11,700 ±  3,747  63 
mg/lO0 ml  mg/lO0 ml 
Total C4  64  39.5  ±  10.2  100  72  41).4 +  8.3  ItX) 
Low C4 individuals  25  28.6  ±  2.9  39  11  28.8  ±  3.3  15 
ltigh C4 individuals  39  46.1  ±  6.7  61  61  43.3  ±  6.5  85 
results of the second bleeding 6 mo later are shown in Fig. 3; as for C2 the C4 protein 
concentrations in  six  HLA-DW2  positive and  six  HLA-DW2  negative  individuals 
were stable and highly correlated to the first determination (r =  0.996, P <  0.001). 
An analysis of the relationship between C2 and C4 levels in the HLA-DW2 positive 
population (Fig. 4) revealed a positive correlation (r =  0.338, P <  0.01). 
HLA-A  and  -B  Analysis.  Allele  frequencies  for  the  HLA-A  and  -B  series  were 
calculated in both the HLA-DW2 positive and HLA-DW2 negative population. No 
gross deviations from the expected frequencies were found (i.e. increase of the HLA- 
B7 and B 18 allele frequencies in the HLA-DW2 positive population due to the known 
linkage disequilibrium). This can be taken as evidence that there is no further strong 
association of low or high C2 and C4 levels to the HLA-A,B system. 
Discussion 
To  our  knowledge  this  report  is  the  first  giving  information  about  the  genetic 
linkage between (22 and (24 serum levels and the HLA system in healthy unrelated 
individuals. Previous studies on this topic dealt nearly exclusively,  with families where 
one or more  members were  identified as  (22  or (]4  homozygous deficient patients 
mostly  affected  by  autoimmune  or  rheumatic  diseases.  These  studies  gave  clear 
evidence that  the (22  deficiency gene(s)  ((22  °)  segregates with  HLA haplotypes in 
families and that this deficient gene is in linkage disequilibrium with the HLA-DW2 
allele, possibly with the entire haplotype HLA-A 10,B 18,DW2. 
The genetic linkage between a (24 deficiency gene (C4 °) and the HLA complex is 
firmly established  only in  two  families  (30,  32).  From  the data  in  the  literature it 
seems that the deficiency of the fourth component of complement is far less frequent 
than the (22 deficiency. There were three reasons for us to study C2 as well C4 serum 
levels  in  HLA-DW2  positive  and  negative  healthy  individuals.  First  the  gametic 
association between C2 deficiency and HLA-DW2, second the known linkage of C4 
deficiency to the HLA complex, and third the close functional relationship between 
(22 and C4 in the activation of the complement cascade. 
The results of serum C2 titers in 62 healthy unrelated HLA-DW2 positive blood 
donors showed a stable and clearly bimodal distribution with approximately % of the 
tested donors belonging to the low serum level group. We also observed in the HLA- 
DW2 negative population (n  =  64) a  bimodal distribution of C2 serum levels here 
with  approximately V3 of the donors having low serum  levels. If one compares the 
frequencies of low and  high  C2  serum  levels in  the  HLA-DW2  positive versus the 708 
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HLA-DW2 negative population  there is a  statistically significant difference showing 
that  a  preselection  for the  genetic  trait  HLA-DW2 results  in  a  higher  incidence  of 
persons with lower C2 serum levels. 
In families  with  C2  homozygous deficient  members  three  categories  of C2 serum 
levels  are  observed:  zero  (C2°/C2°),  intermediate  (C2°/C2),  and  high  (C2/C2) 
indicating a  codominant inheritance.  The intermediate  C2 serum levels are found in 
family  members  who  have  inherited  one  deficient  and  one  normal  C2  gene,  i.e. 
heterozygous deficient, and high serum levels correspond to persons receiving a normal 
C2 gene in double dose. Based on these family data we conclude that the very distinct 
group of low  (= intermediate)  C2 serum  levels in our study could represent  hetero- 
zygous  deficient  individuals  (C2°/C2).  This  is  further  supported  by  the  observed 
higher  incidence  of  intermediate  C2  serum  levels  in  the  preselected  HLA-DW2 
positive population. A definite proof for this assumption can only be given by further 
family studies  including the determination  of the known C2 polymorphism  (51-53). 
If the  C2  deficient  gene  is  allelic  to  the  allotypic  variants  of C2,  C2°/C2  persons 
should appear as "hemizygotes" expressing only,one C2 allele. 
An unexpected result was our finding that a preselection for HLA-DW2 results also 
in an increase of individuals having low C4 protein levels. Taking the same criteria as 
for the C2 study one can assume that the very distinct group with low (= intermediate) CH.  NERL,  H.  GROSSE-WILDE,  AND G.  VALET  709 
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C4 levels consists of persons carrying a C4 deficient gene. Although a genetic linkage 
between C4 levels and the HLA-system is clearly evident  (30, 32)  a  formal proof for 
C4 deficiency in a  heterozygous state cannot be given from the above data alone. As 
already discussed for the C2 deficient heterozygotes typing for the allotypic variants 
for C4 (54, 55) would give further information. A positive association of both low C2 
and  C4  levels with  the  HLA-DW2  allele  is  further corroborated  by a  statistically 
significant correlation coefficient (Fig. 4). If one assumes that the intermediate serum 
levels represent  heterozygous deficiencies for C2 or C4 it is possible to estimate the 
frequency for C2°/C2 ° or C4°/C4 ° individuals. From our material the frequency for 
C2°/C2 °  would  be  17.5%,  and  for C4°/C4 °  3.8%.  Although  C2°/C2 °  deficiency 
was found in healthy individuals both values appear too high in comparison to the 
observed  incidence  of deficiencies.  Since our study  deals  only with  the  association 
between HLA-DW2 and C2 and C4 on a phenotypical level the estimated C2°/C2 ° 
and C4°/C4 °  frequencies have to be taken very tentatively. Besides the C2 and C4 
deficiency  gene(s)  associated  with  HLA-DW2  this  apparent  overestimate  may  be 
caused  by other  factors which  are involved in  the  regulation  of C2  and C4  serum 
levels. Another explanation could be the existence of an HLA-DW2 associated gene 
regulating the levels of both complement components. In this case our observation is 
not  necessarily  linked  to  C2  or  C4  deficiencies.  Nevertheless  this  would  offer  an 
interesting view on how the HLA antigen status is related to the biologically acting 
complement  cascade.  The  extension  of  our  studies  could  give  in  the  future  an 
understanding  of the  biological  mechanisms  involved  in  the  realization  of HLA 
associated diseases. 
In  summary our  study  in  healthy  unrelated  individuals  underlines  the  gametic 
association  between  C2 °  and  HLA-DW2  which  has  already  been  established  in 
families with various autoimmune diseases. In addition,  the C4 serum levels appear 
to be regulated also by gene(s) associated with the HLA-DW2 allele. 
These genes are possibly identical with the C2 and C4 deficiency genes known to 
be present on chromosome no. 6 linked to the HLA system. An alternative explanation 
would be the assumption of an HLA-DW2 associated gene that regulates C2 and C4 
levels. 710  LOW C2 AND C4 LEVELS ASSOCIATED WITtt  HLA-DW2 
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As a practical consequence of  this study, it is important for the clinical interpretation 
of complement titration  data  to realize that  serum  C2  and  C4  titers  are  not  only 
determined by production and consumption but also by genetic factors. 
Summary 
HLA typed unrelated healthy individuals (HLA-DW2 positive n  =  64, and HLA- 
DW2  negative n  =  72)  were investigated  for their C2  functional activity and  C4 
serum protein levels. For the C2 and C4 levels a  bimodal distribution was found in 
HLA-DW2 positive and HLA-DW2 negative individuals. HLA-DW2 positive persons 
had a significantly higher incidence of low C2 and C4 serum levels. Our data support 
the  concept  that  genes  governing  C2  as  well  as  C4  serum  levels  are  in  linkage 
disequilibrium with the HLA-DW2 allele of the major histocompatibility complex. 
HLA-A,B typing of the tested persons was performed by Doctors E. D. Albert and S. Scholz, 
University of Munich, Dr. Ch. Rittner, University of Bonn, and Dr. J. Bertrams,  University of 
Essen. 
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